Home
Opaleye Management, 10% Owner: Eton Pharmaceuticals ETON Buy · Filed 25/06/12
Trade details
- Type
- Insider buy
- Amount
- $79,100
- Shares · price
- 5,000 sh · $15.82 a share
- Held after
- 2,770,000 sh
- Trade date
- 25/06/10
- Filed
- 25/06/12
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 1 insiders
- Holding change
- +0.2%
Eton Pharmaceuticals trades, last 26 weeks
What else happened in Eton Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 25/05/11~25/07/10Opaleye Management's recent trades
- Opaleye Management
BuyGrace Therapeutics
BuyGrace Therapeutics
GRCE
$16.4K
7,849 sh
$16.4K
Filed 10/01
Traded 09/29
- Opaleye Management
BuyGrace Therapeutics
BuyGrace Therapeutics
GRCE
$20.5K
9,771 sh
$20.5K
Filed 10/01
Traded 09/21
- Opaleye Management
BuyGrace Therapeutics
BuyGrace Therapeutics
GRCE
$11.2K
5,318 sh
$11.2K
Filed 10/01
Traded 09/23
- Opaleye Management
BuyAlpha Cognition
BuyAlpha Cognition
ACOG
$157.1K
18,337 sh
$157.1K
Filed 09/28
Traded 09/24
- Opaleye Management
BuyAlpha Cognition
BuyAlpha Cognition
ACOG
$113.7K
13,426 sh
$113.7K
Filed 09/28
Traded 09/25